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Abstract
Epidurals used for labor are common regional anesthesia techniques that are easily placed
and controlled, while providing the most reliable method of pain relief in obstetrics for
parturient women. Local anesthetics, narcotics, and/or combinations of the two are
administered through epidurals to treat labor pain. Hence, the choice of medication is
important, as it can highly influence outcomes of pain relief. The purpose of this DNP
project was to evaluate the effectiveness of a new service line medication, bupivacaine
0.1% with fentanyl 2mcg/ml, to treat labor pain in parturient women at a rural community
hospital in southern California guided by the Johns Hopkins Nursing Evidence Based
Practice Model. A quantitative, time-series, retrospective, and prospective design was
used to analyze data from a convenience sampling of participants who received
ropivacaine and bupivacaine with fentanyl. Paired samples t-tests compared differences
in verbal pain scores before and after epidural insertion with initial boluses alongside
frequencies of top-off boluses required to achieve adequate pain relief. Findings showed
that both medications were equally effective in the treatment of labor pain within the first
hour after the intervention. However, the ropivacaine group had higher rebolus demands,
while the bupivacaine with fentanyl group had only a minimal amount. The complexity
of healthcare today demands inter and intraprofessional collaboration to improve and
sustain best outcomes for high quality care. The bupivacaine with fentanyl project
impacts social change by improving the quality of care for parturient women, addressing
the fear and anxiety of childbirth pain, and highlighting the importance of collaboration
with other clinical providers to change practice using the evidence.
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Section 1: Overview of the Evidence
Introduction
Epidural analgesia for parturient women, is a common regional technique used
during childbirth involving the use of local anesthetics, narcotics, and/or a combination of
the two to decrease labor pain (Fehder & Gennaro, 1993). Epidurals eventually replaced
caudal anesthesia in the 1960’s because it was easier to control, easier to place, and had
less inherent contamination risks (Fehder & Gennaro, 1993).
Epidural analgesia offers the most reliable pain relief with the least amount of
side effects for the longest period of time in labor when compared to all other forms of
pharmacological methods (Pirbudak, Tuncer, Kocoglu, Goksu, & Celik, 2002).
However, the choice of anesthetic medication is important and can highly influence the
outcome of pain relief. This DNP project evaluated the effectiveness of a new service
line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, to treat labor pain in parturient
women at a southern California hospital (SCH). I provide an overview of the project, a
review of best evidence, and outline how this medication in the treatment of labor pain
will be measured and evaluated. In section 1, I will discuss ropivacaine and
bupivacaine’s pharmacological properties, its role in pain relief at SCH, the surrounding
circumstances that led to the development of the practice initiative, problem statement,
purpose statement, purpose objectives, purpose questions, significance to practice, and
operational definitions.
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Background/Context
Ropivacaine and bupivacaine are two local anesthetics that are commonly used to
treat labor pain with a wide amount of success (Pirbudak, Tuncer, Kocoglu, Goksu, &
Celik, 2002). Ropivacaine is a newer amide local anesthetic that is structurally similar to
bupivacaine but has the reduced propensity to cause motor blocks and cardiotoxicity
(Feldman & Covino, 1988). With these added benefits, it has gained popularity in
obstetrics for analgesia. However, recent studies have suggested that ropivacaine
administered epidurally is approximately 40% less potent than bupivacaine based on an
index of 50% effective dose’ (Polley, Columb, Naughton, Wagner, & Van de Ven, 1999).
Ropivacaine has been in use for approximately 1.5 years at SCH after
discontinuation of bupivacaine 0.125% with fentanyl 1.6 mcg/ml. Since the medication
change, anesthesia peers and labor/delivery registered nurses (RNs) have voiced
dissatisfaction. Anesthesia peers stated that they had higher workload demands because
parturients treated with ropivacaine often require more top off boluses of bupivacaine
0.25% to provide adequate pain relief. However, top off boluses are not long-term
solutions and are only effective up to approximately 60 minutes (Zaric, Nydahl, &
Philipson, 1996). Labor and delivery RNs stated that patients who received ropivacaine
solutions expressed higher verbal pain scores than previous patients who received
bupivacaine. In light of these observations, a recent medical decision was made to switch
back to bupivacaine with fentanyl, albeit, a slightly lower concentration of bupivacaine
was ordered to decrease the chances of adverse events and conversions to cesarean
sections, which are often attributed to bupivacaine.
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The labor and delivery unit at SCH is comprised of four laboring rooms, two
triage beds, and one operating room. The average monthly census ranges from 40 to 50
parturient women who deliver vaginally, of which 78% receive epidural anesthesia for
labor. The national average is 61%. After receiving permission from management, a
retrospective chart audit was performed that focused on top-off bolus rates for all
parturients who delivered in January 2014. Results showed that at least half the patients
with epidurals who received ropivacaine for labor required at least one top off bolus of
additional local anesthetic between the time periods where the epidurals were placed and
the fetus was delivered. The results of the January audit revealed unusually high rates of
top-off boluses that could indicate that ropivacaine was not highly effective in providing
adequate pain relief. Out of 46 parturient women with epidurals for labor, 22 parturient
women required additional boluses. Moreover, documented verbal pain scores were all
above seven out of 10 on a numeric pain rating scale, which were reported to the
anesthesia provider just prior to the top off bolus.
Problem Statement
Ropivacaine 0.2% administered for labor analgesia provided suboptimal relief for
parturient women at SCH as noted by an increased number of patients’ requests for
rescue boluses, higher verbal pain scores, and feedback from labor and delivery RNs and
anesthesia staff as compared to the previous discontinued medication, bupivacaine
0.125% with fentanyl 2mcg/ml.
This problem is contrary to what the literature states in regard to analgesia used
during labor. Most studies indicated that ropivacaine administered through continuous
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epidurals in equipotent doses was as effective as bupivacaine when used to treat labor
pain (Dresner, Freeman, Calow, Quinn, & Bamber, 2000). Although the prior
ropivacaine solution used for labor analgesia was equipotent to the previous bupivacaine
with fentanyl solution, it failed to produce adequate pain relief. Ropivacaine was the
medication used for labor analgesia from January 2014 to January 2015, while
bupivacaine was the medication used prior to the switch. A retrospective chart audit of
top-off boluses and verbal pain scores in January 2013 of parturient women who received
bupivacaine suggests that the medication is far more effective than ropivacaine. Out of
45 parturient women, only five required additional boluses. Two out of those five
parturient women had verbal pain scores above seven out of 10 on a numeric pain scale
just prior to the bolus.
Purpose Statement
The purpose of this DNP project was to determine the efficacy of the new service
line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, for the treatment of labor pain
in parturient women at SCH. The purpose was to create positive labor experiences for
parturient women by treating labor pain with medications that have good safety profiles,
are cost-effective, and require minimal to almost no additional top off boluses. Effective
pain relief medications will allow patients to allocate more quality time to other areas of
labor such as breathing and relaxation techniques. For healthcare providers, effective
pain relief would decrease time demands in providing comfort measures, which may
permit more time for coaching and individualized care.
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Project Objectives
There were two objectives for the project. The first was to achieve verbal pain scores of
the parturient women of less than four out of 10 post epidural insertion/initial loading
dose within 60 minutes. The zero through 10 numeric pain rating scale is a reliable
diagnostic tool promoted by the National Initiative on Pain Control (NIPC) to assess the
severity and quality of pain experienced by patients (McCaffery & Pasero, 1999).
According to the numeric pain scale, pain scores that are less than four out of 10 indicate
mild to almost no pain at all is a reasonable goal and will serve as the target threshold for
this initiative. Verbal pain scores were collected by the anesthesia provider 5 minutes
prior to epidural insertion and 60 minutes post epidural insertion/initial loading dose
administration and patient controlled epidural analgesia (PCEA) basal rate infusions.
The second objective was to achieve a top-off bolus rate of less than 10%. This
figure was obtained taking into consideration the rebolus events based on retrospective
chart reviews. Bupivacaine 0.125% with fentanyl 2mcg/ml, the medication used prior to
January 2014, had a rebolus rate of 11%. Ropivacaine 0.2%, the medication used just
prior to January 2015, had a rebolus rate of 48%. Reboluses of additional local anesthetic
introduce the potential for more adverse effects to the parturient woman and fetus, such
as cardiotoxicity and delayed labor progression (Dresner, Freeman, Calow, Quinn, &
Bamber, 2000). Therefore, it would be more ideal to minimize the number of reboluses
the parturient women receive.
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Project Questions
There were two project questions. The first question asked: Does bupivacaine
0.1% with fentanyl 2mcg/ml reduce labor pain to adequate levels safely and timely? The
goal was to achieve pain scores of less than four out of 10 on a numeric pain rating scale
within 60 minutes post epidural insertion/initial medication bolus. Bupivacaine 0.1% is a
slightly lower concentration than the bupivacaine solution used in the past. The risks of
cardiotoxicity and adverse effects are decreased with lower concentrations.
The second question asked: Does bupivacaine 0.1% with fentanyl 2mcg/ml
provide sustainable labor pain relief where additional top off boluses are not required.
The desired goal was a target threshold of less than 10% occurrence. Decreased rates of
additional boluses may indicate that parturient women have adequate and/or tolerable
pain levels.
Significance of the Project
Evidence based practice (EBP) supports clinical practice by developing strategies
according to the best available scientific evidence (Strand & Parkkinen, 2014). The main
role of the evidence is to associate causal inferences with the expected results from
available interventions, thereby tying relevant causal knowledge to decision making in
the clinical arena. Therefore, a proper understanding of the precise content of the causes
and the inferences they enter into are important.
Although much of the medical literature notes that ropivacaine has a similar
potency and duration to that of bupivacaine with less cardiotoxic effects (Dresner et al.,
2000), the reverse seems true at SCH. Implementation of a bupivacaine initiative to
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investigate its role in labor analgesia relief would add to the ever-increasing knowledge
base aimed at providing high quality care at cost effective means. Finding a suitable
medication that would provide adequate analgesia needing less frequent rebolusing of
additional local anesthetics improves quality of care by decreasing exposure of
unnecessary medications to the parturient and relieving increased workloads on
anesthesia personnel.
Lastly, effective pain relief for parturient women can improve the overall birthing
experience. One study indicated that labor pain was directly associated with
posttraumatic stress, which in turn had a correlation with patients’ overall birthing
experiences (Garthus-Niegel, Knoph, Soest, Nielsen, & Eberhard-Gran, 2014). Treating
labor pain effectively would decrease posttraumatic stress episodes (Garthus-Niegel et
al., 2014).
Reduction of Gaps
Childbirth is often accompanied by pain. The overall goal of the bupivacaine
with fentanyl initiative is to provide effective pain relief for parturient women safely,
adequately, and promptly. Labor pain relief is a major component of the birthing
process. Historically, pain management was often neglected because of societal
expectations that women should endure the process without supplemental analgesics.
However, traumatic labor experiences have been shown to cause psychologically
detrimental effects (Campbell, 2003). For example, ineffective pain relief highly
influenced parturient women’s long-term decisions to have another baby (Iliadou, 2009).
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Hence, the goal is to provide effective labor analgesia that would not dissuade parturients
from future birthing experiences.
Epidural insertion rates at SCH are approximately 78% as compared to the
national average of 61% (Osterman & Martin, 2011). Given SCH’s above national
average epidural insertion rates, it makes prudent sense to consider the management of
labor pain via the epidural method a high priority. A reduction of gaps addresses the
translation of evidence-based knowledge into clinical practice by use of techniques or
modes of therapy that work. To be useful, evidence should enable clinicians to practice
better, meaning better outcomes and satisfaction for patients. However, ropivacaine used
for labor analgesia through continuous patient controlled epidural infusion in SCH’s
population is an example where a medication did not work effectively based on
healthcare provider feedback, high number of top-off boluses, and verbal pain scores
from parturient women compared to patients that received bupivacaine with fentanyl.
Evidence has pointed out that lower concentrations of bupivacaine and the addition of
narcotics such as fentanyl can provide high quality analgesia with minimal side effects at
cost effective means (Dresner et al., 2000). As front line providers in the labor and
delivery department, nurse anesthetists have a duty to provide prompt, effective, and safe
labor analgesia relief so that parturient women receive the highest quality care and
positive overall birthing experiences.
Implications for Social Change
Pain experienced in childbirth is a complex phenomenon that can trigger fear.
Fear associated with childbirth is considered harmful, and has been shown to affect a
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woman’s self-esteem and her ability to handle labor pain effectively (Karlsdottir,
Halldorsdottir, & Lundgren, 2014). In fact, studies have shown that women actually
experience higher levels of labor pain than they had expected prior to the childbirth
(Lally, Murtagh, Macphail, & Thomson, 2008; Iliadou, 2009). Unmet expectations and
negative birth experiences have been shown to influence women’s decisions about future
childbearing (Gottvall & Waldenstrom, 2002).
The American Association of Colleges of Nursing (AACN) advocates for DNP
practitioners to have a wide array of knowledge gleaned from the sciences and to be well
prepared to translate that knowledge into the daily demands of clinical practice (AACN,
2006). Nursing science has created a large body of information that could guide nursing
practice and has extended the scientific underpinnings of the discipline (AACN, 2006).
Information received from this initiative would contribute to the body of nursing
knowledge aimed at improving health care quality for the parturient woman and her
family. Epidurals placed for labor coupled with safe and effective medications can allay
patients’ fears and anxiety during a significant period in their lives. Treating labor pain
effectively and informing parturient women adequately by addressing their concerns and
presenting realistic expectations about epidural pain management may increase
satisfaction surrounding the childbirth experience.
Definition of Terms
The following terms were used in this initiative concerning bupivacaine with
fentanyl:
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Anesthesia: A partial or complete loss of sensation for the purposes of surgery or
medical procedure, with or without loss of consciousness (Barash et al., 2013).
Epidural anesthesia: Anesthesia that is produced by the injection of local
anesthetics into the peridural space outside the spinal cord, often used during childbirth
delivery, lower extremity surgeries, and postoperative pain management (Morgan,
Mikhail, & Murray, 2006).
Evidence-based practice: A problem solving approach to clinical decision making
that incorporates the best available evidence along with clinical expertise and patient
preferences and values (Grove, Burns, & Gray, 2013).
Labor pain: Crampy, diffused or localized lower abdominal pain, sometimes
referred to the back and perineum coinciding with uterine contractions. The pain may be
supplemented with nausea, vomiting, and diaphoresis (Miller et al., 2005). The
operational definition of pain relief is defined as a verbal pain score of less than four out
of 10 based on numeric pain rating scale ranging from zero to 10. Zero is no pain
whereas 10 is extreme pain.
Patient controlled epidural analgesia: A technique of pain relief where a local
anesthetic and opioid are administered by a pump into the epidural space allowing
patients to self administer the analgesic mixtures on demand for supplemental doses in
addition to the basal rate infusion (Miller et al., 2005).
Rescue boluses: Supplemental local anesthetic medications of bupivacaine 0.25%
ranging from six to eight milliliters that are administered via the epidural catheter by
anesthesia providers to achieve pain relief for the parturient (Barash et al., 2013).
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Assumptions
I made several assumptions about the success of the initiative. First, the
pharmacy at SCH would purchase or create enough supplies of the medication to meet
the demand. Second, the labor and delivery department and obstetricians would be
supportive in efforts to address labor pain management. Third, patients would have
realistic expectations of what an epidural used for labor can and cannot do. Fourth,
patients would be honest in reporting their pain scores to providers. Lastly, labor and
delivery nurses would evaluate parturient women’s pain and notify the anesthesia
provider of the need for top-off boluses.
Limitations
There were three limitations of the initiative that should be noted. The first
limitation related to inconsistent practices of all anesthesia providers. All anesthesia
providers have varying degrees of experience and different skillsets in the placement of
epidurals. There are several methods in the placement of epidurals such as the hanging
drop technique, loss of resistance to air technique or the loss of resistance to saline
technique (Morgan et al., 2006). All have arguable advantages and disadvantages but a
“gold” standard has not been established.
The second limitation pertained to consistent implementation and compliance of
pre-procedural protocols performed by labor and delivery RNs. Epidural placement is an
invasive procedure that can have detrimental consequences for the parturient woman and
fetus such as hypotension, excessive bleeding from the site, infection, spinal headaches,
and even paralysis (Miller et al., 2005). Hence, it was imperative that nurses followed
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protocols that mitigated or eliminated the expected physiological effects of local
anesthetics administered through epidurals.
Lastly, one of the challenges of accurately measuring and treating labor pain was
its subjective nature. The verbal pain score based on Likert scales or numeric visual
analog scales have been the most commonly used and trusted tools to measure subjective
pain in subjects. However, the health literacy of individuals and language barriers
needed to be considered in pain assessment with those tools.
Summary
Epidural analgesia is the most reliable and longest lasting pain relief method with
the least amount of side effects compared to all other forms of pharmacological methods
for the birthing process. Although the literature is saturated with studies that indicate that
ropivacaine is equally comparable to bupivacaine in pain relief, it is not the case at SCH.
In this section, I discussed the context of the problem in regards to labor pain
relief at SCH, the initiative’s purpose and objectives, and the questions that are asked
relative to those objectives. Labor pain management is a high priority at SCH due to the
above national average rates of epidurals used for childbirth. Addressing the
pharmacological agent that is responsible for unsatisfactory relief of labor pain is an
important issue to explore.
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Section 2: Review of Literature and Theoretical/Conceptual Framework
Introduction
In section 2, I discuss the review of literature and search strategies that I
performed to address the bupivacaine with fentanyl initiative. At the end of the section, I
present a theoretical/conceptual model that was utilized to help guide the project. The
Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) model focuses in depth on
the evidence-based practice (EBP) process, which involves the identification of clinical
practice questions, the discovery and evaluation of scientific evidence, and the translation
of that evidence into clinical practice.
General Literature Search
I conducted a systematic literature review was done using PubMed, the
Cumulative Index of Nursing and Allied Health (CINAHL), Medline, ProQuest Nursing
and Allied Health Source, and Cochrane Database of Systematic Reviews. Key search
terms used were regional anesthesia, ropivacaine, bupivacaine, labor, postoperative
analgesia, and epidural with limitations set to full-text. A cumulative of 162 peer
reviewed articles, books, and web domains were reviewed relevant to the topic. One
hundred and thirty-five of those sources were rejected because they were either published
in languages other than English, were dated more than two decades, sample sizes were
not reported or did not include explicit comparisons between ropivacaine and
bupivacaine. Inclusion criteria were that publications were peer-reviewed to assure a
measure of quality, randomization of participants to either the bupivacaine or ropivacaine
groups, and results reported allowed quantitative analysis. Twenty-seven studies met the
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project criteria and were included for the literature review. The studies selected consisted
of peer-reviewed articles, double-blind randomized controlled trials (RCT), metaanalyses, prospective and retrospective studies, and case reports with initial publication
dates of 1997.
Specific Literature
Most women experience severe pain with childbirth, similar to pain caused by
complex regional pain syndromes or amputations of an extremity (Melzack, 1984).
Although untreated pain is not life threatening in healthy parturient women, it can have
severe neuropsychological consequences, such as posttraumatic stress disorder, postnatal
depression, and impaired cognitive function in the postpartum period (Hawkins, 2010).
Men are also affected by pain associated with labor. Capogna, Camorcia, and Stirparo
(2007) found that first-time fathers whose significant others who had received an epidural
felt three times more helpful and involved and had less anxiety and stress compared to
men whose significant others did not receive epidurals (Capogna, Camorcia, & Stirparo,
2007). The specific literature subsection will discuss epidurals for labor, patient
controlled epidural analgesia, bupivacaine and ropivacaine profiles including motor block
potential, cardiotoxicity, and potency, and the addition of narcotics to local anesthetics.
Epidurals for Labor
Effective pain relief coupled with minimal motor block are essential components
of an ideal epidural for labor analgesia (Finegold, Mandell, & Ramanathan, 2000).
Epidural analgesia for labor and delivery involves the use of a local anesthetic with or
without the addition of an opioid into the lumbar epidural space (Catterall & Mackie,
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2006). The injected medications diffuse slowly across the dura and eventually bath the
spinal nerve roots causing a decrease in catecholamine production and providing
segmental sympathetic and sensory nerve blockades (Hawkins, 2010). The resultant
sensory nerve block is the relief of pain and the sympathetic block causes a reduction in
vascular resistance significantly improving uteroplacental bloodflow in healthy
parturients (Hawkins, 2010). Increased bloodflow to the uterus and placenta ensures that
the fetus receives adequate oxygenation and nutrition.
Epidurals administered to provide effective labor pain relief have a longstanding
history in obstetrics. Studies comparing the effectiveness of epidurals to other modes of
analgesic therapy, such as intravenous narcotics, were done with positive results
favouring epidurals (Dickinson, Paech, Mcdonald, & Evans, 2003; Catterall & Mackie,
2006; Hawkins, 2010). One large trial study of 992 nulliparous women indicated
significantly lower pain scores after the administration of epidural analgesia compared to
those who received midwifery support (Dickinson, Paech, Mcdonald, & Evans, 2003). In
the study, pain scores were rated on a scale of zero to 100, with 100 being the worst pain
imaginable based on a visual analog pain scale. Median pain scores prior to the
intervention were 80 in the midwifery group and 85 in the epidural group. Post
intervention median scores for the midwifery group were 75 and median scores for the
epidural group were 27, indicating significant pain score reduction (p<0.001) (Dickinson
et al., 2003).
The study is important in pointing out that epidural analgesic techniques are
significantly more effective in labor pain treatment than intravenous techniques. The
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bupivacaine with fentanyl initiative explored the efficacy of labor pain relief between two
local anesthetic medications administered through epidurals, already established as the
most efficacious and reliable method of analgesic therapy in labor. The investigation of
which medication was more effective will further add to the literature with the purposes
of improving the quality of care in parturient women, while trying to minimize adverse
consequences and negative outcomes.
In a meta-analysis study involving 2703 nulliparous women who participated in
five trials conducted in one facility, median pain scores were significantly reduced after
interventions in the epidural group compared to the meperidine group (p<0.001) (Sharma,
McIntire, Wiley, & Leveno, 2004). Additionally, 95% of women in the epidural group
rated their satisfaction with pain relief as excellent or good compared with 69% of
women in the meperidine group (p<0.001) (Sharma et al., 2004). After the
administration of an epidural and an initial bolus of medication, effective maintenance of
anesthesia can then be achieved through patient controlled epidural analgesia (PCEA)
regimens. The study showed that medications administered through epidural catheters
via PCEA regimens was an effective way to treat labor pain.
Patient controlled epidural analgesia regimens usually involve the dilution of local
anesthetics with or without the addition of opioids administered through the epidural
catheter with basal rate continuous infusions and patient controlled intermittent boluses
(Lim, Ocampo, Supandji, Teoh, & Sia, 2008). Some of the benefits of PCEA regimens
are greater patient satisfaction, lower dose requirements of local anesthetics, reduced
motor blocks, and fewer interventions by anesthesia personnel (Halpern & Joseph, 2002).
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Halpern and Joseph (2002) found in a meta-analysis of 640 patients in nine studies, that
there were fewer overall anesthetic interventions in the PCEA group (95 percent CI,
p<0.0001), less local anethestics infused (95 percent CI, p<0.0001), and less motor
blocks (95 percent CI, p<0.003) compared to the continuous epidural infusion group
(Halpern & Joseph, 2002). Infusion rates and bolus amounts may be adjusted depending
on individual variations to pain responses, stages of labor, and patients’ expectations
about their childbirth experiences. The two most commonly used local anesthetics
administered through PCEA regimens are bupivacaine and ropivacaine. Both
bupivacaine and ropivacaine are administered via PCEA formats with continuous basal
rate infusions through epidural catheters at SCH. The DNP project showed that the
addition of fentanyl allowed bupivacaine concentrations to be lowered, while providing
effective analgesia and minimizing anesthesia interventions, such as, top-off boluses.
Bupivacaine and Ropivacaine
Bupivacaine is the most commonly used medication administered for epidural
analgesia in labor because of its widespread availability, low costs, and relative safety
profile (Sah, Vallejo, Phelps, & Mandell, 2007). It has a rapid onset and its duration is
long-lasting. Bupivacaine has also been shown to provide longer lasting analgesia than
other local anesthetics even after sensations return (Catterall & Mackie, 2006). However,
claims of bupivacaine’s longer duration of analgesia are controversial. Muir, Writer, and
Douglas (1997) posited that a ropivacaine 0.25% group (n=34) and a bupivacaine 0.25%
group (n=26) had no significant differences in the onset times of pain relief, quality of
analgesia, and duration of analgesia in a prospective, double-blind, randomized multi-
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center study of 60 nulliparous labouring women when medications were administered
epidurally by intermittent top-ups (95 percent CI, p<0.001). Although the study showed
the efficacy of labor pain relief through intermittent boluses of ropivacaine and
bupivacaine, the results indicated that both medications had nearly identical outcomes. In
fact, the bupivacaine concentration used in the study is more than twice the concentration
used in the DNP project, while ropivacaine concentrations are similar. The DNP project
showed that decreased bupivacaine concentrations with the addition of opioids provided
effective labor pain relief as compared to moderate concentration levels of ropivacaine.
Sah, Vallejo, Phelps, and Mandell (2007) later added that there were no
significant differences in visual analog pain scores and Bromage scores in the measured
time intervals between ropivacaine and bupivacaine. In their prospective, randomized,
double-blind study, 100 American Society of Anesthesiologists (ASA) physical status I
and II, full-term, nulliparous women were placed into two groups, bupivacaine (n=50)
and ropivacaine (n=50), and received initial boluses of medication and a continuous
infusion of local anesthetics, either ropivacaine 0.2% or bupivacaine 0.125%. The
average onset time to achieve a T10 level sensory level block in the bupivacaine group
was 11 minutes as compared to the ropivacaine group, which was 9 minutes. Although
the difference was statistically significant (p<0.05), it was clinically irrelevant. The
medication concentrations used in the study are almost identical to the medication
concentrations in the DNP project. The study results are important in pointing out that
pain scores and motor block effects are similar. The DNP project added further evidence
to the study by comparing similar concentrations in a different population sampling.
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Modern obstetric analgesia teams aim to minimize motor blocks while eliminating
the perception of pain from cervical dilation and uterine contractions (Lacassie, Habib,
Lacassie, & Columb, 2007). Ropivacaine is an amide local anesthetic that has gained
popularity over the years in obstetric epidural analgesia due to its reduced propensity for
causing cardiotoxic effects and its greater affinity for sensory fibers compared with
bupivacaine (Feldman & Covino, 1988). Thus, ropivacaine would be a more ideal
medication choice in the labor and delivery ward. In a toxicology human study,
ropivacaine proved less toxic than bupivacaine when administered by intravenous
infusion with regards to signs and symptoms of mild central nervous system and
cardiotoxic effects (Katz, Bridenbaugh, Knarr, Helton, & Denson, 1990). However, the
cardiotoxic effects were often attributed to high concentrations of bupivacaine, such as
0.75%, and have been discontinued across all clinical settings (Albright, 1984).
Bupivacaine solutions of 0.75% are not available or utilized at SCH. The DNP project
used a bupivacaine solution that was 6.5 times less concentrated, therefore neurotoxicity
and cardiotoxicity issues was a negligible factor.
Chang, Ladd, and Copeland (2001) performed comparative studies of the direct
effects of bupivacaine and ropivacaine on sheep hearts. Doses ranging from trivial to
toxic amounts were administered to explore what humans would receive if the injections
were accidently administered via intravenous routes. The findings indicated that both
ropivacaine and bupivacaine have similar abilities to cause fatal cardiac arrhythmias and
death (Chang, Ladd, & Copeland, 2001). Although ropivacaine produced less
myocardial depression and arrhythmias in the study, its lower potency requires higher
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concentrations to achieve equianesthetic doses to those of bupivacaine, thereby offsetting
its intrinsic cardiac toxicity profile. The DNP project explored the efficacy of labor pain
relief between ropivacaine 0.2% and bupivacaine 0.1% with fentanyl 2mcg/ml. If higher
concentrations of ropivacaine are needed just to equal the analgesic effects of lowered
concentrations of bupivacaine at SCH, cardiotoxic and neurotoxic profiles of ropivacaine
increase. Thereby, the safety benefits of ropivacaine are dampened, risks for the
parturient woman increase, and costs for the facility escalate.
The perceived advantage of a reduced motor block potential is another popular
belief in the push for ropivacaine in obstetrics. Despite the expected advantages of
reduced motor blocks due to reduced potencies, especially for childbirth, earlier studies
that compared ropivacaine with bupivacaine for epidural analgesia for women in labor
showed no significant benefits when administered through intermittent top-ups,
continuous infusion, and continuous infusion with patient controlled top-ups (Eddleston
et al., 1996; Owen, D’Angelo, & Geranchar, 1998). Finegold, Mandell, and Ramanathan
(2000) further expanded on the notion that different intensities of motor block were
clinically similar in labor outcomes in a double-blind, randomized, 100 parturient study
in patients who received ropivacaine or bupivacaine. The researchers argued that
although the bupivacaine group had 25% higher levels of motor block within the first
hour of medication administration, outcomes of successful delivery were similar
(Finegold et al., 2000). Interestingly, out of the ropivacaine group (n=50), 11 parturient
women had to deliver via caesarean section versus eight patients in the bupivacaine group
(n=50)(Finegold et al., 2000). Although it is not the focus of the DNP project, the
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findings of the project showed that bupivacaine’s motor blocking effects was a nonissue
in the context of labor outcomes at SCH.
Since the introduction of ropivacaine into clinical practice, its potency has been
an issue. In one prospective, double-blind, randomized control trial of 126 single-term,
ASA physical statuses I and II parturient women, potency ratios for
ropivacaine:bupivacaine was statistically significant favouring bupivacaine (p<0.001). It
was suggested that ropivacaine has a 0.6 relative potency rating to that of bupivacaine.
Researchers have suggested that ropivacaine is approximately 40% less potent than
bupivacaine (Capogna, Celleno, Fusco, Lyons, & Columb, 1999; Dresner et al., 2000;
Chua, Sia, & Ocampo, 2001). Hence, large doses of ropivacaine would still be needed to
evoke equal responses to that of lower doses of bupivacaine. If large doses of
ropivacaine are needed to match the potency of bupivacaine, the intended benefits of
safety are lost. Moreover, higher concentrations and bulk supplies of ropivacaine are
more than twice the purchase costs of bupivacaine with fentanyl. It was also
hypothesized that ropivacaine would provide a better quality of analgesia because of its
lower potency and a more theorized rostral spread of the anesthetic. However, pain relief
and cephalad spread between ropivacaine and bupivacaine were found to have similar
results (Lacassie et al., 2007). Ropivacaine’s concentration at SCH was 0.2%, considered
equipotent to bupivacaine 0.125% by a vast majority of researchers in the literature
(Capogna et al., 1999; Dresner et al., 2000; Owen et al., 1998). The bupivacaine with
fentanyl initiative adds to the literature in distinguishing whether the potency of
ropivacaine is a factor in labor pain relief even at equipotent doses.
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The majority of studies suggest that ropivacaine and bupivacaine have equivalent
effects of labor analgesia relief in parturients (Chua, Sia, & Ocampo, 2001; Polley,
Columb, Naughton, Wagner, & Van de Ven, 1999; Dresner et al., 2000; Fehder &
Gennaro, 1993). Although few, there are some conflicting studies that indicate better
duration and quality of labor analgesia relief when bupivacaine is used compared to
ropivacaine (Merson, 2001; Capogna et al., 1999). However, the cited cause of
bupivacaine’s effectiveness in the treatment of labor pain was attributed to the mixture of
opioids. The addition of an opioid to local anesthetic solutions can help treat missed
segments, perineal pressure, and maximize efficacy and maternal satisfaction (Dresner et
al., 2000) while promoting the idea that smaller doses of anesthetics infused translates
into better safety profiles and decreased incidences of adverse effects. Animal studies
suggest that local anesthetics and opioids have a synergistic effect and that the binding of
opioid receptors hyperpolarizes the membranes thereby decreasing nerve impulse
transmissions (Melzack, 1984). However, some of the drawbacks of adding opioids to
local anesthetics include pruritus, hypotension, neuraxial infections, urinary retention,
vomiting, and respiratory depression (Bucklin, Chestnut, & Hawkins, 2002). When it
comes to the addition of opioids to local anesthetic solutions, factors such as those listed
previously should be taken into consideration depending on the context of the situation.
The initiative showed that the addition of fentanyl, a potent opioid, to low concentrations
of bupivacaine was a solution to providing high quality labor analgesia at safe, costeffective means at SCH.
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General Literature
Ropivacaine and bupivacaine are also used for other purposes alongside maternal
labor – mainly postoperative pain control for patients who undergo lower limb,
orthopedic, gynecological, and abdominal surgeries. Postoperative pain management is a
key component of anesthetic practice because untreated pain can be detrimental
(Apfelbaum, Chen, Mehta, & Gan, 2003). Effective treatment of pain helps restore
normal physiological processes such as ventilation and coughing, which thereby
promotes early ambulation, prevention of infections, and shortened hospital stays
(Sawhney et al., 2015).
Until recently, bupivacaine was the most commonly used medication for the
management of postoperative epidural analgesia. The toxic effects of bupivacaine on the
central nervous system and cardiovascular system are less harsh with ropivacaine when
plasma levels are comparable (Casati & Baciarello, 2006). However, the claim that
ropivacaine produces less motor block while providing equivalent analgesia compared to
bupivacaine is also controversial outside of maternal analgesia (Merson, 2001). Berti,
Fanelli, Casati, and Albertin (2000) compared the analgesic efficacy and incidences of
motor block during patient supplemented epidural analgesia with either
ropivacaine/fentanyl or bupivacaine/fentanyl solutions in patients that underwent major
abdominal surgeries. In the prospective, double-blind, randomized study of 32 ASA
physical status I-III patients, both ropivacaine/fentanyl and bupivacaine/fentanyl mixtures
provided similar relief of analgesia, motor block, levels of sedation, and pulse oximetry
readings (Berti, Fanelli, Casati, & Albertin, 2000). A more recent study compared both
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ropivacaine and bupivacaine for lower extremity orthopedic procedures, which indicated
that there were no significant differences in block parameters (Chandran, Hemalatha, &
Viswanathan, 2014). In another prospective, double-blind, randomized trial of 60
patients that underwent total knee replacements, findings suggested that there were no
statistically significant differences in pain, side effects, and motor block between
ropivacaine/morphine and bupivacaine/morphine groups (p<0.05)(Zaric, Christiansen,
Haastrup, & Sandberg, 2004). Although it is desirable to have patients ambulate almost
immediately after total knee replacement surgeries, the findings indicate that earlier
mobilization with the use of ropivacaine compared to bupivacaine are indistinguishable.
It is then when the cost factor analysis also comes to question.
At a time when facilities face economic constraints, cost-effectiveness should be
taken into account when any new agents are considered. In one study, an economic
evaluation of bupivacaine with fentanyl versus ropivacaine alone administered for post
operative pain control after total knee replacements showed that bupivacaine with
fentanyl was more cost-effective and provided more patient satisfaction than ropivacaine
because it provided better quality of analgesia (Pitimana-aree, Visalyaputra, Komoltri,
Muangman, & Al, 2005). Results indicated that the bupivacaine/fentanyl group (n=35)
had higher pain satisfaction scores and an eighteen percent cost savings compared with
the ropivacaine group (n=35). Ropivacaine is approximately double the price of
bupivacaine on an equipotent basis. Facilities should perform sensitivity analyses to
make reliable comparisons of medications.

25
Theoretical/Conceptual Framework
The Johns Hopkins Nursing evidence-based practice model (JHNEBP) was used
as the framework for the project. The conceptual model consists of three major
components of practice, research, and education (Buchko & Robinson, 2012). The model
points out that research and non-research factors form the basis for clinical decisionmaking. The Johns Hopkins Nursing evidence-based practice model also indicates that
both internal and external factors should be taken into consideration before a certain
practice can be changed (Buchko & Robinson, 2012). The three phases of the model are
practice question (P), evidence (E), and translation (T) (Buchko & Robinson, 2012). In
the first phase, a practice question is identified and explored. The second phase involves
a systematic review and synthesis of research and non-research components/factors
(Buchko & Robinson, 2012). The synthesis may include all types of research studies and
all types of non-research factors, such as, experience, quality improvement and financial
data, clinical expertise, and patient preferences. The third phase is translation, where the
evidence-based practice team can determine if new practice guidelines or interventions
can be implemented or are feasible for implementation (Buchko & Robinson, 2012). The
translation phase includes possibly piloting the study, measuring outcomes, and
disseminating the findings (Buchko & Robinson, 2012). The model may shed light on
relative potencies of the medications, financial costs, and additional solutions.
The Johns Hopkins Nursing evidence-based practice model (JHNEBP) and its
three step process, PET, was used to help guide the bupivacaine with fentanyl project by
providing a straightforward, problem-solving approach designed to meet the needs of the

26
practicing nurse by incorporating most recent research findings and best practices. The
first step is the practice question. For the project, effective labor analgesia relief is the
topic of interest and which medication is considered more effective in providing labor
pain relief, ropivacaine or bupivacaine with fentanyl. The second step is concerned with
the evidence that pertains to both research and non-research factors. Research evidence
deals with information that is derived from ropivacaine/bupivacaine controlled trial
studies, case reports, meta-analyses, and other widely published forms of dissemination.
Non-research evidence includes specific information obtained from the project itself,
such as, provider and patient feedback, verbal pain scores, and number of top-off boluses.
The third step focuses on translation where the new practice change is evaluated to
determine if it is feasible for implementation and whether it is sustainable. Financial and
cultural factors are two issues that may be taken into consideration. For example, would
the new medication cost the institution more revenue and would there be purchasing
issues? Would every anesthesia provider be open to administering the new medication?
Summary
Bupivacaine is a popular local anesthetic that is used in obstetrical anesthesia due
to its superior analgesic effects. It has a long-standing, successful track record and a
wide variety of uses alongside maternal labor, such as, orthopedic and abdominal
procedures. However, its cardiotoxic effects in high concentrations have pushed for the
creation of an isomer, ropivacaine. The main advantage of ropivacaine is its wide margin
of safety and motor sparing effects, something that is attractive in obstetrical anesthesia.
Most studies indicate an equivalent analgesic effect when ropivacaine and bupivacaine
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are compared to each other. Decreased potencies, lesser quality of analgesia relief, and
high costs of ropivacaine have been its crutch in a time where health care facilities look
for cost-effective means to provide high quality care. Although a majority of the
evidence seems to suggest that ropivacaine causes less motor block and has less
cardiotoxic and central nervous system effects, the benefits are offset by its decreased
potency. To achieve equipotent doses to that of bupivacaine, higher doses of ropivacaine
are necessary, which would then increase costs. Facilities would need to perform a
sensitivity analyses to determine the cost-effectiveness of ropivacaine versus
bupivacaine.
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Section 3: Methodology
Introduction

Section 3 includes the methodology that I utilized to explore the effectiveness of
the new service line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, administered
via PCEA infusion in parturient women at SCH. There were two objectives for the
project. The first objective was to achieve verbal pain scores of less than four out of 10
on a numeric pain scale ranging from zero to 10 within 60 minutes of epidural insertion
and initial loading dose. The second objective was to achieve a rebolus rate of less than
10% throughout the remainder of the course of labor until the delivery of the fetus. The
project design, population and sampling, data collection, instruments, data analysis,
protection of human subjects, and project evaluation plan will also be discussed.

Project Design
I used a prospective, time-series, quantitative design was used to explore the
efficacy of a new service line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, in
parturient women. I used a quantitative design because of its focus on patient groups and
patterns that are unique to this special group, its investigation of the effectiveness of an
intervention where outcomes are measureable, such as, verbal pain scores, and its ability
to establish correlational or causal relationships between variables. Verbal pain scores
before and after the intervention and number of top-off boluses are quantifiable and can
be analyzed statistically to determine if there are clinically significant differences
between the variables: ropivacaine and bupivacaine.
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Ropivacaine was discontinued at SCH in January 2015. Therefore, data about the
effects of ropivacaine on laboring parturients was obtained retrospectively from archived
patient records that were electronically scanned. Verbal pain scores that were reported to
the anesthesia provider just prior to the bolus and an hour after epidural administration
and initial bolus was recorded and statistically analyzed through paired samples t-tests to
determine clinically significant differences. Moderate to high occurrences of rebolus
rates coupled with high verbal pain scores indicated that ropivacaine was not effective in
relieving labor pain because verbal pain scores remained high necessitating supplemental
local anesthetics. Bupivacaine with fentanyl was concurrently started along with
ropivacaine in January 2015. Data such as numerical verbal pain scores, top-off boluses,
epidural insertions, medication administration, preprocedural assessments, consents, and
all other relevant data for the initiative were obtained and performed by one provider
prospectively for 1 month.
Population and Sampling
The initiative focused on all parturients in the Morongo basin community
admitted for labor at a 55-bed rural community hospital in Southern California. Both
retrospective and prospective portions of the initiative had inclusion/exclusion criteria.
The inclusion criteria for all parturients was that they will be American Society of
Anesthesiologist’s (ASA) physical statuses I or II; less than 100 kilograms in weight; less
than 40 years old; cervically dilated less than five cm; and, have no previous history of
cesarean section(s). The retrospective component of the initiative was based on a1month chart audit convenience sampling of parturient women who received epidurals
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from multiple providers and were placed on ropivacaine solutions. The prospective
component of the initiative was based on a 1-month convenience sampling of parturient
women who labored at SCH, received epidurals from one anesthesia provider, and were
placed on bupivacaine with fentanyl solutions. Both retrospective and prospective
portions of the initiative were based on non-probability sampling methods due to the low
number of deliveries at the facility coupled with project completion time constraints.
Data Collection
I collected the entire data set for both retrospective and prospective components
of the initiative. The retrospective component involved chart audits accessed through
“idoc”, a computer program where past medical records were scanned and saved onto
password protected computer files. First, the delivery room register was reviewed for 1
particular month. In the register, I noted the methods of delivery, anesthesia provider
name, patient names, dates, and times of delivery. I filtered out any parturient women
who did not have epidurals and did not deliver vaginally through the delivery register
initial screening. Second, I used the medical record numbers of the parturient women to
bring up their medical information on idoc. I obtained initial and post epidural verbal
pain scores, top-off boluses, preanesthetic health and physical information, vital signs,
and list of medications. Third, once the information was obtained, I deidentified all
parturient women and assigned numerical codes.
The prospective portion included the same data as the retrospective portion of the
initiative. However, the prospective component followed one standard technique by one
anesthesia provider. I performed a preanesthetic evaluation to collect information about
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health and physical histories. I then assigned an ASA physical status to the patient along
with a numerical code at the conclusion of the interview. Then, a total of one liter of
Lactated ringer’s solution was given intravenously to every parturient woman 30 minutes
prior to epidural insertion. During the intravenous bolus, I presented the numeric pain
rating scale depicted on a chart visually and discussed the chart to ensure understanding
about verbal pain scores. The numeric pain rating scale ranged from zero to 10. Zero
was equated with no pain while 10 was the equivalent of the worst pain imaginable.
Once an adequate understanding of verbal pain scores was addressed, I recorded a preblock score. I used the loss of resistance to saline technique to locate the epidural space
at the L3-4 or L4-5 interspace with the parturient woman in the sitting position using a
seventeen-gauge Tuohy needle (Braun). Following epidural insertion and initial bolus,
all parturient women were placed in the left uterine displacement position for
approximately 1 hour. Verbal pain scores were obtained 5 minutes prior to epidural
insertion and 1 hour post epidural insertion and initial medication bolus. I obtained data
on additional top off boluses of bupivacaine 0.25% until delivery of the fetus.
Instruments
I used two instruments for the initiative. The first instrument was the facility’s
preanesthetic evaluation form, which contained information about the health and history
of patients. Comorbidities, surgical histories, allergies, and heights/weights of the
patients were examples of some of the information that was tabulated and then assigned
an ASA physical status. Participants that were healthy to fairly healthy, ASA statuses of
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I or II, were included for the initiative. This information can be found in SCH’s
preanesthetic record (Appendix A).
The second instrument I used was a visual/verbal analog scale that depicted a pain
score on a horizontal line from zero to 10, zero being no pain and 10 being the worst pain
imaginable (Appendix B). Visual analog scales are frequently used to measure selfreports of fear and pain in both children and adults (Chapman & Kirby-Turner, 2002).
The measures for the initiative were simplified to only include verbal pain scores ranging
from zero to 10.
Protection of Human Subjects
I sought approval from administration, the chief compliance officer of SCH, and
Walden University’s internal review board (IRB) before initiation of the project. I
reassured all participants in the prospective group about the purposes of the project and
that intervention strategies were not different from the standardized norm. Data collected
for the initiative were readily accessible only to me and stored in confidential computer
files protected by an encrypted password.
Data Analysis
I used a paired samples t-test to determine the significance between bupivacaine
with fentanyl and ropivacaine and the adequacy of pain relief based on verbal pain scores
collected pre and post intervention. Paired samples t-tests are parametric analyses that
compare mean differences in the same group of subjects at two different points in time
(Polit, 2010). However, the paired samples t-test requires that paired score differences
are independent and normally distributed (Grove et al., 2013). Frequency distributions
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were used to determine top-off bolus rates of parturient women who receive bupivacaine
with fentanyl or ropivacaine. Statistical analysis was performed using SPSS Version 21
for MAC, and significance levels of p < 0.05.
There were two project questions. The first project question asked: Does
bupivacaine 0.1% with fentanyl 2mcg/ml reduce labor pain to adequate levels safely and
timely? The retrospective portion of the initiative addressed the efficacy of ropivacaine
in labor pain relief by comparing verbal pain scores obtained 5 minutes prior to the
epidural/initial bolus and verbal pain scores obtained 60 minutes post epidural/initial
bolus. Likewise, in the prospective component of the project, verbal pain scores were
collected 5 minutes prior to and 60 minutes after the intervention. The goal was to
achieve pain scores of less than four out of 10 on a numeric pain rating scale within 60
minutes post epidural insertion/initial medication bolus. Lower pain scores after the
intervention indicated whether the intervention was effective in relieving labor pain
initially.
The second question asked: Does bupivacaine 0.1% with fentanyl provide
sustainable labor pain relief where additional top off boluses are not required? The
desired goal was a target threshold of less than 10% occurrence. Decreased rates of
additional boluses may indicate that parturients have adequate and/or tolerable pain levels
and the medication provides sustainable labor pain relief negating the need for epidural
replacements or rescue analgesics. The number of top-off boluses required to obtain
labor pain relief were recorded from the retrospective portion of the project from
parturient women who received ropivacaine. Similarly, the number of top-off boluses
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required to obtain adequate labor pain relief were recorded from the prospective
component of the project from parturient women who received bupivacaine with
fentanyl.
Project Evaluation
I used an evaluation plan was used to determine if ropivacaine and bupivacaine
with fentanyl solutions provided adequate labor pain relief and discussed the strengths
and limitations of the project. The use of a summative evaluation was appropriate for the
bupivacaine with fentanyl initiative because it scrutinized program outcomes to
determine the effectiveness of interventions (Spaulding, 2008). I used the summative
evaluation to address three aspects important to the project: Intended goals of the project,
anticipated outcomes, and intended/unintended impact and a goals evaluation to address
project questions by determining if the two medications, ropivacaine and bupivacaine
with fentanyl, adequately decrease verbal pain scores and minimize top-off boluses,
thereby, providing sustainable labor pain relief during childbirth. I used an outcomes
evaluation to explore whether the program caused palpable effects on specifically defined
target outcomes in parturient women. I used an impact evaluation to provide a broader
assessment of how the initiative affected the organization or community. After the
collection and analysis of data, I evaluated whether: (a) Ropivacaine and/or bupivacaine
with fentanyl were indeed effective in providing adequate, sustainable relief of labor pain
for parturient women in the Morongo basin community; (b) the sample population was
representative of the community district; (c) patient and hospital personnel were satisfied
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with the service provided; and (d) what processes could be improved upon to better the
outcomes.
Summary
In the bupivacaine with fentanyl initiative, I explored the efficacy of ropivacaine
and bupivacaine with fentanyl utilizing both retrospective and prospective, time-series,
quantitative designs. Data gathered from the participants were analyzed through
statistical analysis to determine clinically significant relationships of verbal pain scores
pre and post epidural insertion and initial medication bolus. The long-term efficacy of
each medication was determined by the analysis of number of top-off boluses that
parturient women received. Participant protection rights were addressed by obtaining
permission from the facility’s administration, chief compliance officer, and Walden
University’s IRB. A summative evaluation plan was used to determine if ropivacaine and
bupivacaine with fentanyl provided adequate labor pain relief in parturients at SCH.
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Section 4: Findings, Discussion, and Implications
Introduction
The purpose of this DNP project was to determine the efficacy of the new service
line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, as compared to the
discontinued medication, ropivacaine 0.2%, for the treatment of labor pain in parturient
women at SCH. The effectiveness of ropivacaine and bupivacaine with fentanyl in the
treatment of labor pain was determined through retrospective, time-series, quantitative
analysis and prospective, time-series, quantitative analysis, respectively.
I implemented the project at a rural community hospital in the Morongo Basin
area located in Southern California. The bupivacaine with fentanyl proposal was first
presented to the anesthesia, obstetrical, and surgical departments because ropivacaine
0.2% administered for labor analgesia seemed to provide suboptimal relief for parturient
women as noted by an increased number of patients’ requests for rescue boluses, higher
verbal pain scores, and feedback from labor and delivery nurses and anesthesia staff as
compared to the previous discontinued medication, bupivacaine 0.125% with fentanyl
1.6mcg/ml. The focus of this section will be on project findings, practice implications,
project outcomes, project strengths and limitations, and a personal self-analysis relative
to the project.
Summary and Evaluation of Findings
My goal in conducting this project was to evaluate the effectiveness of a new
service line medication, bupivacaine 0.1% with fentanyl 2mcg/ml, to treat labor pain in
parturient women at SCH by investigating two questions. Does bupivacaine 0.1% with
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fentanyl 2mcg/ml reduce labor pain to adequate levels safely and timely and does
bupivacaine 0.1% with fentanyl 2mcg/ml provide sustainable labor pain relief where
additional top off boluses are not required? To address the project questions, the
following objectives were recognized:
1. To achieve pain scores of less than four out of 10 on a numeric pain rating
scale within 60 minutes post epidural insertion/initial medication bolus.
2. To decrease rates of medication rebolusing of less than 10% occurrence.
I incorporated a quantitative, time-series design to determine causal or
correlational relationships between the independent and dependent variables. Statistical
analysis was done through SPSS version 21.0 to determine relationships between the
independent variables, ropivacaine and bupivacaine with fentanyl, to the dependent
variables, verbal pain scores and number of top-off boluses. The numeric pain rating
scale was used to determine the efficacy of the medications by analyzing the assigned
value of scores before and after epidural placement. A value of zero indicated no pain
while a value of 10 indicated severe or worst imaginable pain. The participants voiced
understanding after initial instruction just prior to the epidural placement and were asked
to give an initial score. The participants were asked to give a follow up score 60 minutes
after the initial bolus and continuous delivery of medication via patient controlled
epidural analgesia (PCEA) pumps.
Project Objective 1
Thirty-two participants were included in the ropivacaine group for analysis.
There were a total of 48 deliveries of which 16 participants underwent caesarean section
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and six parturient women did not meet the inclusion/exclusion criteria due to age, weight,
and ASA physical statuses. Ages of the participants ranged from 18 to 36 years old with
a mean age of 25.3 (Table 1). All parturient women in the ropivacaine group were
interviewed prior to epidural placement with the use of the preanesthesia evaluation form
(Appendix A).
Twenty-nine participants were included in the bupivacaine with fentanyl group
for analysis. A total of 33 parturient women received epidurals for labor. However, 4
parturient women did not meet inclusion/exclusion criteria either because of age, weight,
physical ASA status, or conversion to cesarean section. Ages of the participants ranged
from 19 to 33 years old with a mean age of 25 (Table 1). All parturient women in the
bupivacaine with fentanyl group were interviewed prior to the placement of an epidural
using the same preanesthesia evaluation form (Appendix A).
Table 1
Mean ages of parturient women
Minimum
Ropivacaine group
18
Bupivacaine group
19

Maximum
36
33

Mean
25.3
25

Numerical pain scores before and after the intervention and number of top-off
boluses were recorded on the first page of the anesthetic record (Appendix A). A paired
samples t-test was used to determine clinically significant differences in numerical pain
scores pre- and postepidural insertion with initial loading dose in the ropivacaine group.
Pre- and postepidural numerical pain scores indicated mean scores of 9.0 and 1.1,
respectively (Table 2).
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Numerical pain scores before and after the intervention and number of top-off
boluses were also recorded on the first page of the anesthetic record (Appendix A). A
paired samples t-test was used to determine clinically significant differences in numerical
pain scores pre- and postepidural insertion with initial loading dose in the bupivacaine
with fentanyl group. Pre- and postepidural numerical pain scores in the bupivacaine with
fentanyl group indicated mean scores of 8.7 and 0.9, respectively (Table 2).
Table 2
Pre and post pain scores
Pre-epidural ropivacaine
Post-epidural ropivacaine

Mean
9.0
1.1

Significance
p<0.01

Degrees of Freedom
31

Pre-epidural bupivacaine
8.7
p<0.01
28
Post-epidural bupivacaine
0.9
________________________________________________________________________
Project Objective 2
In the ropivacaine group, approximately 19% of the 32 parturient women did not
require top-off boluses. However, 71% of the parturient women required at least one topoff bolus to achieve adequate pain control indicated on a histogram (Figure 1). In the
bupivacaine with fentanyl group, 90% of the 29 parturient women did not require top-off
boluses, while only 10% required at least one top-off bolus to achieve adequate pain
control (Figure 2)
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Figure 1. Top-off boluses of parturient women at SCH ropivacaine group.

Figure 2. Top-off boluses of parturient women at SCH bupivacaine with fentanyl group.

41
I collected data for the ropivacaine group from retrospective chart reviews based
on a 1 month (January 2015) audit of all participants who received epidurals for labor and
met all inclusion/exclusion criteria. I considered a 1 month audit as adequate given that
the average number of deliveries at SCH ranged from 30 to 45 per month consistently
over the past 2 years. I also collected data for the bupivacaine with fentanyl group
prospectively in the latter half of mid December 2016 through mid-January 2017 for a
total of 4 weeks based on a convenience sampling of all participants who received
epidurals for labor. The purpose in the timing of the retrospective January audit was to
align as much as possible seasonal deliveries in accordance with the planned prospective
portion of the project.
Discussion of Findings in the Context of Literature and Frameworks
The literature strongly supported that bupivacaine is a popular local anesthetic
that is used in obstetrical anesthesia due to its superior analgesic effects (Dickinson,
Paech, Mcdonald, & Evans, 2003). Bupivacaine has a long-standing, successful track
record and a wide variety of uses alongside maternal labor. However, its cardiotoxic
effects when given in high concentrations have pushed for the creation of an isomer,
ropivacaine. The main advantage of ropivacaine is its wide margin of safety and motor
sparing effects, something that is attractive in obstetrical anesthesia. Most studies
indicate an equivalent analgesic effect when ropivacaine and bupivacaine are compared
to each other (Dickinson, Paech, Mcdonald, & Evans, 2003; Catterall & Mackie, 2006;
Finegold, Mandell, & Ramanathan, 2000).
The results of the numeric pain score analysis showed that both ropivacaine and
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bupivacaine with fentanyl groups were equally effective in the treatment of labor pain
within the first hour after the intervention. However, the ropivacaine group had higher
occurrences of rebolus demands, while the bupivacaine with fentanyl group had only a
minimal amount. Sample sizes of both groups were very similar and the results of the
analysis correlate with patient and staff verbal feedback regarding medication efficacy.
Additionally, parturient women in the bupivacaine with fentanyl group did not experience
cardiotoxic or excessive motor block effects. The results correlate with Merson’s (2001)
study where bupivacaine provides better duration and quality of labor analgesia relief
than ropivacaine.
The theoretical framework used for the project was the JHNEBP, which consists
of three major components: practice, research, and education (Buchko & Robinson,
2012). The model accounts for both research and nonresearch factors and both internal
and external factors in the context of clinical decision-making (Bondmass, 2011). In the
first component of the model, practice question, I addressed the topics of effective labor
analgesia relief and which medication was considered more effective in providing labor
pain relief, ropivacaine or bupivacaine with fentanyl. In the second component,
evidence, I incorporated both research and non-research factors, such as findings from the
literature and patient/staff verbal feedback. Lastly, in the third component, translation, I
focused on whether bupivacaine with fentanyl was feasible for implementation and
sustainable. The pharmacy department and anesthesia staff were interviewed to receive
feedback on long-term purchasing and practice issues.
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Implications
Policy
Advanced practice nurses possess the knowledge, skills, and experience regarding
research and evidence based practice, allowing them to be powerful advocates for
healthcare policies (Terry, 2015). Healthcare policies contribute the framework for
delivery of healthcare services whether in governmental regulations and/or institutional
standards or procedures (Terry, 2015). In the end, they either enhance or impede
healthcare delivery to patient populations. Utilizing those instruments to their full
potential is a challenge that all DNPs should undertake.
This DNP project was a quality improvement initiative aimed at evaluating the
effectiveness of a new service line medication, bupivacaine with fentanyl, for parturient
women in a rural community hospital in southern California. The QI project is one of
many examples of how advanced practice nurses can be engaged where policy decisions
are made that influence and shape how rules govern nursing at an institution. Taking into
consideration the safety profiles of new medications administered in an especially
vulnerable patient population is of utmost importance. The institution should have some
sort of formal and organized manner of evaluating the effectiveness of new medications
while also monitoring and documenting unwanted side effects. Decreasing or
minimizing the amount of adverse medication reactions while improving patient
satisfaction is aligned with the institution’s vision and goals and also with the Institute of
Medicine’s (2001) stance on nurses being champions of policy and social change.
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Practice
The bupivacaine with fentanyl initiative provided evidence that sometimes newer
and often more expensive medications do not necessarily provide better outcomes or
improve patient/provider satisfaction. The initiative showed that a methodical and logical
process could be implemented to evaluate the effectiveness of new service line
medications administered in clinical practice. The DNP curriculum emphasizes
leadership for evidence-based practice, which involves the translation of research into
practice, the evaluation of evidence, the application of research in clinical decisionmaking, and the implementation of innovative methods and tools to change practice
(Zaccagnini & White, 2011). From the results of the initiative, an older and less
expensive medication provided less top-off boluses, which in turn provided more
sustainable labor pain relief in parturient women at SCH.
Research
For the DNP clinician, selection of the research problem is arguably the most
crucial element in the research process (Terry, 2015). If the selected problem is not
viable and testable, the whole process can waste valuable hours and financial resources
while also creating frustration for the researcher. The core of the idea may come from
patients, fellow colleagues, or from an indirect source, such as auditing, if the provider
works in a quality management or administration role (Fitzpatrick & Whall, 2005). In
this case, the problem stemmed from both direct and indirect sources.
The results of the QI project showed that bupivacaine with fentanyl was more
effective in providing sustainable labor pain relief as compared to ropivacaine, thereby
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improving the quality of care at SCH. This finding is contrary to most current evidence
in mainstream literature (Eddleston et al., 1996; Owen, D’Angelo, & Geranchar, 1998;
Polley, Columb, Naughton, Wagner, & Van de Ven, 1999; Dresner et al., 2000; Fehder &
Gennaro, 1993), which suggests that ropivacaine is equipotent to bupivacaine with less
side effects and motor sparing benefits. Future research needs to be conducted to show
the effectiveness of administering bupivacaine with fentanyl in a larger Morongo Basin
population over a longer period of time to determine generalizability and reliability. The
results can then determine if bupivacaine with fentanyl does provide more sustainable
labor pain relief in parturient women. Future research may also explore motor sparing
effects, hemodynamics, patient satisfaction, and conversion to cesarean sections.
Social Change
The first implication for social change was the collaboration of other clinical
providers to change practice using the evidence. Today’s complexity of healthcare
demands inter and intraprofessional collaboration to improve and sustain best outcomes
for high quality care (Wojciechowski, Pearsall, Murphy, & French, 2016). Teams
involved in continuous quality improvement projects may magnify and reveal competing
mindsets of individuals and different practice strategies. However, in dynamic healthcare
environments, individuals and systems need to be fluid and adaptable. Improvement is a
never-ending journey that staff members need to be made aware of. With leadership
support, the goal is for all participants to contribute to problem solving and to improve
the design that adds value as defined by the client (Toussaint & Gerard, 2010).
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The second implication for social change was to improve the quality of care for
parturient women in the Morongo Basin community by also addressing the fear and
anxiety of childbirth pain. Childbirth pain is a complex phenomenon that can trigger fear
to those who have not experienced it. The fear is real, considered harmful, and has been
shown to affect a woman’s self-esteem and the ability to handle labor pain effectively
(Karlsdottir, Halldorsdottir, & Lundgren, 2014). Unmet expectations and negative birth
experiences have been shown to influence women’s decisions about future childbearing
(Gottvall & Waldenstrom, 2002). With the Information received from the project, I
would be able contribute to the body of nursing knowledge aimed at improving health
care quality for the parturient and her family in an emotionally significant period in their
lives. When providers place epidurals for labor and administer safe and effective
medications, they can allay patients’ fears and anxiety during hospitalization where levels
of vulnerability are high. Treating labor pain effectively with safe medications,
informing parturient women adequately by addressing their concerns, and presenting
realistic expectations about epidural pain management may increase satisfaction
surrounding the childbirth experience.
Project Strengths and Limitations
Strengths
Strengths of the project were the use of the numeric pain rating scale and the
implementation, collection, and analysis of project data by one lead project provider. The
numeric pain rating scale is a trusted, long standing diagnostic tool that has been used in
numerous disciplines and practices to evaluative subjective pain (Buchko & Robinson,
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2012). Since a numeric value is placed in correlation with the pain, degrees of pain can
be distinguished from one another. Hence, higher scores can indicate greater pain
intensity. I implemented the same practice technique for the prospective bupivacaine
with fentanyl group, such as placement of epidurals at similar levels of the spine, initial
bolus amounts, fluid pre-loading in participants, and communication between myself and
participants. Consistent practices ensure less confounding variables.
Limitations
There were two main limitations to the project. First, the data collected from the
retrospective ropivacaine group had less credibility due to confounding variables.
Although retrospective studies allow investigators to quickly use past data conveniently
to inform current research questions, the database should be used based on sound
rationale (Abbott, Barton, Terhorst, & Shembel, 2016). A few considerations include
relevant data sources, data extraction methods, statistical procedures, and cautious
interpretation of the findings. Although initial medication boluses and collection of
numeric pain scale scores at designated times were similar to the prospective bupivacaine
with fentanyl group, multiple providers placed the epidurals, communication between the
providers and patients were most likely different, basal rate infusions varied between
patients depending on provider preferences, and fluid pre-loading was sometimes omitted
or not charted. Additionally, retrospective studies generally do not have the
methodological rigor that is necessary to eliminate bias (Abbott, Barton, Terhorst, &
Shembel, 2016). However, that is not to say that the information extracted from
retrospective studies are not valuable. Through the retrospective audit of ropivacaine
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patients, I offered preliminary findings that base clinical importance on the detection,
management, and therapy of labor pain in parturient women at SCH.
Second, a convenience sampling was used for the project in both retrospective
and prospective portions of the project due to time and resource constraints. A
retrospective audit was necessary for the ropivacaine group because the medication was
discontinued in January 2015 at SCH. The prospective portion of the project was feasible
with the bupivacaine group, which comes with more rigor and control for bias. However,
due to the low volume of deliveries at the institution, a convenience sampling was used to
decrease the level of sampling error. To offer some control and limit selection bias of the
prospective portion of the project, I selected some stringent inclusion and exclusion
criteria and collected participant data over four weeks each. Despite some of those
measures, I collected data from a rural community hospital that may not be representative
of the community at large further limiting the generalizability of the findings. An
accurate study needs to include all facets of a population with randomization (Polit,
2010). To add generalizability of the results, project teams would need to include
randomization of participants with standardized practice techniques of providers.
Recommendations for Remediation of Limitations in Future Work
A major limitation of the QI project was the comparison of two different
medications from a retrospective and prospective standpoint. There is less control with
retrospective studies as compared to prospective studies. Provider biases, practice
techniques, communication, and fluid prebolusing can differ greatly and be widely
inconsistent. Researchers who use prospective approaches have more control of
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confounding variables and have more precise estimates about the outcomes or relative
risks of outcomes based on exposure (Grove et al., 2013).
A more reliable and more generalizable project would be the comparison of both
medications strictly from a prospective approach over a longer period of time with the
randomization of larger sample sizes. Providers would need to implement a standardized
technique of epidural placement and adhere to consistent communication and
preintervention protocols. However, the challenge of performing a larger scale, more
time consuming project as such would require adequate support from institution
stakeholders, management, and most importantly, cooperation from anesthesia providers
and labor/delivery RNs. Those involved in the project would need to present expected
outcomes and benefits of the project in a clear manner and aligned with the institution’s
vision and goals.
Analysis of Self
As Scholar
Society benefits through scholarship of practice when practitioners give expert
nursing care, evaluate, and constantly improve practice based on evidence-based
knowledge (Loomis, Willard, & Cohen, 2007). Proponents of the DNP degree posit that
nursing scholarship would be enhanced and advanced through doctoral nursing
education, which would raise advanced nursing practice to new levels termed by the
American Association of Colleges of Nursing (AACN) as ‘scholarship of engagement’
(AACN, 2006). Scholarships of engagement occur when theory and research are applied
to clinical settings, tested, amended, and extended (Loomis et al., 2007).
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Throughout the DNP program, I have gained a wealth of didactic knowledge that
could be shared with other colleagues to improve patient outcomes and enhance quality
of care. With the aging population and projected demographic shifts, the demand for
advanced practice nurses and their practice requirements will only increase furthering the
need for additional education. Advanced practice nurses are prepared to work in a
variety of roles once they complete a doctoral program that incorporates research
elements into clinical practice. I have also learned valuable problem solving approaches
and how to search for evidence based knowledge using systematic methods. The
information obtained could also be shared with institution leaders and other community
stakeholders. In turn, I shared methods of searching for high levels of evidence to other
colleagues so they too could explore feasible solutions to clinical problems.
As Practitioner
Practitioners who complete the DNP curriculum are ready for the acceptance of
new advanced practice roles. Some of the major roles are at their place of employment or
healthcare organization and may involve duties such as, influencing healthcare and policy
development, providing leadership, and strengthening interdisciplinary relationships with
other professionals (Kaplan & Brown, 2009). The DNP prepared nurse who conducts
practice and provide care according to the AACN essentials will bring added value to
practice environments and patients. Intangible values include quality and safety
improvement, healthcare institution savings, and improved patient relationships (Mackey,
2009).
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As a practitioner, the clinical experiences have given me a broader look at
healthcare systems operations, workflow efficiency, outdated policies, and a way of
sensing workplace culture. It has made me keenly aware of the need to develop rapport
and effective communication skills with stakeholders and front line clinical staff in order
to accomplish objectives. Those invaluable skills are not taught in textbooks but only
learned through experiences.
As Project Developer
Project developers have many roles and responsibilities. His/her main goals are
to handle tasks that move the project along toward successful completion while reaching
project objectives. As a project developer, I had to understand the inner dynamics of the
project, remind myself of the objectives, learn to communicate with leaders/management
of the institution to move things forward, and allow those who have valuable skills to use
them. Morrill, Taege, & Slater (2010) note that trained, supportive staff and the
acceptance of policies mixed with environmental changes help achieve successful
outcomes.
Adoption of the project is a big step in having the organization consider taking a
small test of change (Terry, 2015). There were some unexpected delays and frustration
when it came to approval and implementation of the project. I realized how important it
was in identifying barriers early in the process, setting up realistic expectations, and
appreciating the value of forming good relationships with leaders and stakeholders in the
institution. Leadership, management, and development often overlap. Ultimately, I
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realized that without the authority that stems from leadership and management, my
project may have shown potential but never materialized.
What does this project mean for future professional development?
The DNP project has given me a strong foundation and experience for future
projects and initiatives. I was able to develop closer professional relationships with key
stakeholders and leaders of the institution who believe in high quality, cost-effective care.
They have already voiced their desire for me to be involved in several upcoming
institution projects. More importantly, I have learned to systematically search, review,
interpret, plan, and implement new or existing evidence in clinical practice. Evidencebased practice has become prominent in many professions, with the emphasis on clinical
decision-making based on the best available evidence from systematic research
(Zaccagnini & White, 2012). I have learned that management’s use of the evidence just
takes it to the next level where parameters are defined for what evidence will be collected
and how the data will be utilized for monitoring, measuring performance, and evaluating.
The data needs to be captured, quantified, and placed on a spreadsheet in a comparative
format to understand if something works or does not work. I have great satisfaction and a
feeling of professional fulfillment when I present new evidence to the institution so an
actual policy is created.
Summary and Conclusions
The overall goal of the development and implementation of the bupivacaine with
fentanyl project was for me to explore the effectiveness of the new service line
medication, bupivacaine 0.1% with fentanyl 2mcg/ml, administered via PCEA infusion in
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parturient women at SCH. There were two objectives for the project. The first objective
was to achieve verbal pain scores of less than four out of 10 on a numeric pain scale
ranging from zero to 10 within 60 minutes of epidural insertion and initial loading dose.
The second objective was to achieve a rebolus rate of less than 10% throughout the
remainder of the course of labor until the delivery of the fetus. I collected data for the
ropivacaine group from retrospective chart reviews based on a 1 month January 2015
audit of all participants who received epidurals for labor and met all inclusion/exclusion
criteria. I also collected data for the bupivacaine with fentanyl group prospectively in
mid December 2016 based on a convenience sampling of all participants who received
epidurals for labor.
I incorporated a quantitative, time-series design to determine causal or
correlational relationships between independent and dependent variables. Thirty-two
participants were included in the ropivacaine group, while 16 participants were included
in the bupivacaine with fentanyl group for analyses. The results indicated that both
ropivacaine and bupivacaine with fentanyl were statistically effective in relieving labor
pain to adequate levels initially. However, the high number of rebolus rates for patients
in the ropivacaine group indicate that bupivacaine with fentanyl provides more
sustainable labor pain relief in parturient women at SCH.
The academic and clinical preparation gleaned from the DNP curriculum has
enabled me to use a wide array of knowledge from the sciences and translate them
quickly to clinical practice. Patient populations and healthcare systems benefit from the
evidence. The DNP curriculum has also helped me to develop, implement, and evaluate
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new clinical practice approaches based on nursing theories and theories from other
disciplines. I look forward to furthering my professional development, promoting health
and patient safety, eliminating health disparities, and fostering excellence in practice.
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Section 5: Scholarly Product
Communicating the findings of a research or quality improvement project is the
final step, which involves developing a report and disseminating it through presentations
and/or publications to a vast array of audiences, such as, policymakers, healthcare
professionals, and healthcare consumers (Grove, Burns, & Gray 2013). Presentations and
published findings help advance the knowledge of a discipline by providing evidencebased practice. Furthermore, dissemination of the findings helps promote the critical
analysis of previous reports or studies, fosters the reproduction of studies, and points out
additional problems (Melnyk & Fineout-Overholt, 2010). Because the QI project was
completed at SCH to determine the efficacy of a new service line medication, I will
present the findings to the institution’s governing board and surgical services staff at the
quarterly medical executive committee meeting. I will generate an abbreviated report
and give an oral presentation via PowerPoint media. PowerPoint slides are an excellent
layout of the project due to easy-to-read fonts, visuals and figures to amplify points, and
creative backgrounds (Grove, Burns, & Gray 2013). Additionally, the abbreviated report
is to be published in the monthly hospital newsletter. Publication of the findings will
alert healthcare consumers of SCH and the Morongo Basin community that quality
improvement and patient safety/satisfaction is of utmost importance to the organization
and the community.
Another setting where findings could be communicated is the annual spring
conference of the California Association of Nurse Anesthetists (CANA) through poster
presentations (Figure 3). The CANA expresses visions about leadership, advocacy, and
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education for nurse anesthetists in California. Poster presentations allow researchers
and/or clinicians to share preliminary findings, answer questions, and interact with other
researchers or providers about their studies (Grove, Burns, & Gray 2013).

Bupivacaine with Fentanyl Quality Improvement Project
By
Irvin Lee CRNA, MS
Walden University

Background
Epidurals used for labor is a common regional anesthesia technique that is
easy to control and fairly easy to place, while providing the most reliable
method of pain relief in obstetrics for laboring parturients (Fehder & Gennaro,
1993 ). Local anesthetics, narcotics, and/or combinations of the two are
administered through epidurals to treat labor pain. Hence, the choice of
medication is important, which can highly influence outcomes of pain relief.
Ropivacaine has been in use for approximately 1.5 years at SCH after
discontinuation of bupivacaine 0.125 percent with fentanyl 1.6 mcg/ml. Since
the medication change, anesthesia peers and labor/delivery registered nurses
(RNs) have voiced dissatisfaction. Anesthesia peers stated that they had
higher workload demands because parturients treated with ropivacaine often
require more top off boluses of bupivacaine 0.25 percent to provide adequate
pain relief. However, top off boluses are not long-term solutions and are only
effective up to approximately 60 minutes. Eventually, ropivacaine was
replaced with a new service line medication, bupivacaine with fentanyl.

Purpose
To determine the efficacy of the new service line medication, bupivacaine 0.1
percent with fentanyl 2mcg/ml, for the treatment of labor pain in parturients at
SCH and to create positive labor experiences for parturients by treating labor
pain with medications that have good safety profiles, are cost-effective, and
require minimal to almost no additional top off boluses. Effective pain relief
medications will allow patients to allocate more quality time to other areas of
labor such as breathing and relaxation techniques. For healthcare providers,
effective pain relief would decrease time demands in providing comfort
measures, which may permit more time for coaching and individualized care.

Significance to Practice
Although much of the medical literature notes that ropivacaine has a similar
potency and duration to that of bupivacaine with less cardiotoxic effects
(Dresner et al., 2000), the reverse seems true at SCH. Implementation of a
bupivacaine initiative to investigate its role in labor analgesia relief would add
to the ever-increasing knowledge base aimed at providing high quality care at
cost effective means. Finding a suitable medication that would provide
adequate analgesia needing less frequent rebolusing of additional local
anesthetics improves quality of care by decreasing exposure of unnecessary
medications to the parturient and relieving increased workloads on anesthesia
personnel.

Project Objectives
1. To achieve verbal pain scores of the parturients of less than four out of ten
post epidural insertion/initial loading dose within sixty minutes.
2. To achieve a top-off bolus rate of less than ten percent.

Data/Results

Conclusions

- Thirty-two participants were included in the ropivacaine group while
twenty-nine participants were included in the bupivacaine with fentanyl
group for analysis.
- Ages of the participants in the ropivacaine group ranged from 18 to 36
years old with a mean age of 25.3.
- Ages of the participants ranged from 19 to 33 years old with a mean age of
25.
- Pre and post epidural numerical pain scores for the ropivacaine group
indicated mean scores of 9.0 and 1.1, respectively.
- Pre and post epidural numerical pain scores in the bupivacaine with
fentanyl group indicated mean scores of 8.7 and 0.9, respectively.
- In the ropivacaine group, approximately 19 percent of the 32 parturients
did not require top-off boluses. However, 71 percent of the parturients
required at least one top-off bolus to achieve adequate pain control
indicated on a histogram (Figure 1).
- In the bupivacaine with fentanyl group, 90% of the 29 parturients did not
require top-off boluses, while only 10 percent required at least one top-off
bolus to achieve adequate pain control (Figure 2).

The results of the numeric pain score analysis showed that both ropivacaine
and bupivacaine with fentanyl groups were equally effective in the treatment
of labor pain within the first hour after the intervention. However, the
ropivacaine group had higher occurrences of rebolus demands, while the
bupivacaine with fentanyl group had only a minimal amount. Sample sizes of
both groups were very similar and the results of the analysis correlate with
patient and staff verbal feedback regarding medication efficacy. Additionally,
parturients in the bupivacaine with fentanyl group did not experience
cardiotoxic or excessive motor block effects. The results correlate with
Merson’s (2001) study where bupivacaine provides better duration and quality
of labor analgesia relief than ropivacaine.

Design
A prospective, time-series, quantitative design was used to explore the
efficacy of a new service line medication, bupivacaine 0.1 percent with
fentanyl 2mcg/ml, in laboring parturients.
Verbal pain scores that were reported to the anesthesia provider just prior to
the bolus and an hour after epidural administration and initial bolus were
recorded and statistically analyzed through paired samples t tests to determine
clinically significant differences.
Ropivacaine data was based on retrospective chart audits for one month.
Bupivacaine with fentanyl data was based on prospective information
collected by one provider for one month.

Framework
The theoretical framework used for the project was the Johns Hopkins
Nursing evidence-based practice model (JHNEBP). The first component of
the model, practice question, addressed the topics of effective labor analgesia
relief and which medication was considered more effective in providing labor
pain relief, ropivacaine or bupivacaine with fentanyl. The second component,
evidence, incorporated both research and non-research factors, such as
findings from the literature and patient/staff verbal feedback. The third
component, translation, focused on whether bupivacaine with fentanyl was
feasible for implementation. The pharmacy department and anesthesia staff
were interviewed to receive feedback on long-term purchasing and practice
issues.

Figure 1

References
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Ropivacaine 0.2% versus bupivacaine 0.1% with fentanyl: a double blind
comparison for analgesia during labour. British Journal of Anaesthesia, 85(6),
826-829.
Fehder, W., & Gennaro, S. (1993). Recent trends in epidural analgesia for
childbirth. Journal of Perinatal Education, 2(2), 1-6.

Population/Setting
The initiative focused on all parturients in the Morongo basin community
admitted for labor at a fifty-five-bed rural community hospital in Southern
California. The retrospective component of the initiative was based on a onemonth chart audit convenience sampling of parturients who received epidurals
from multiple providers and were placed on ropivacaine solutions. The
prospective component of the initiative based on a one-month convenience
sampling of parturients who labor at SCH, receive epidurals from one
anesthesia provider, and are placed on bupivacaine with fentanyl solutions.

Data Collection

Figure 2

- One anesthesia provider collected the entire data for both retrospective and
prospective components of the initiative.
- The retrospective component involved chart audits in January 2015
accessed through “idoc”.
- The prospective component involved data collection from parturients in
mid December to mid January 2017.
- Verbal pain scores were obtained five minutes prior to epidural insertion
and one-hour post epidural insertion and initial medication bolus. Data on
additional top off boluses of bupivacaine 0.25 percent were obtained until
delivery.
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Figure 3. Bupivacaine with fentanyl quality improvement poster of parturient women in
SCH.
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Mean ages of parturient women
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Ropivacaine group
18
Bupivacaine group
19

Maximum
36
33

Mean
25.3
25
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Pre and post pain scores
Pre-epidural ropivacaine
Post-epidural ropivacaine

Mean
9.0
1.1

Significance
p<0.01

Degrees of Freedom
31

Pre-epidural bupivacaine
8.7
p<0.01
28
Post-epidural bupivacaine
0.9
________________________________________________________________________
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Figure 1. Top-off boluses of parturient women at SCH ropivacaine group.

Figure 2. Top-off boluses of parturient women at SCH bupivacaine with fentanyl group.
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Bupivacaine with Fentanyl Quality Improvement Project
By
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Background
Epidurals used for labor is a common regional anesthesia technique that is
easy to control and fairly easy to place, while providing the most reliable
method of pain relief in obstetrics for laboring parturients (Fehder & Gennaro,
1993 ). Local anesthetics, narcotics, and/or combinations of the two are
administered through epidurals to treat labor pain. Hence, the choice of
medication is important, which can highly influence outcomes of pain relief.
Ropivacaine has been in use for approximately 1.5 years at SCH after
discontinuation of bupivacaine 0.125 percent with fentanyl 1.6 mcg/ml. Since
the medication change, anesthesia peers and labor/delivery registered nurses
(RNs) have voiced dissatisfaction. Anesthesia peers stated that they had
higher workload demands because parturients treated with ropivacaine often
require more top off boluses of bupivacaine 0.25 percent to provide adequate
pain relief. However, top off boluses are not long-term solutions and are only
effective up to approximately 60 minutes. Eventually, ropivacaine was
replaced with a new service line medication, bupivacaine with fentanyl.

Purpose
To determine the efficacy of the new service line medication, bupivacaine 0.1
percent with fentanyl 2mcg/ml, for the treatment of labor pain in parturients at
SCH and to create positive labor experiences for parturients by treating labor
pain with medications that have good safety profiles, are cost-effective, and
require minimal to almost no additional top off boluses. Effective pain relief
medications will allow patients to allocate more quality time to other areas of
labor such as breathing and relaxation techniques. For healthcare providers,
effective pain relief would decrease time demands in providing comfort
measures, which may permit more time for coaching and individualized care.

Significance to Practice
Although much of the medical literature notes that ropivacaine has a similar
potency and duration to that of bupivacaine with less cardiotoxic effects
(Dresner et al., 2000), the reverse seems true at SCH. Implementation of a
bupivacaine initiative to investigate its role in labor analgesia relief would add
to the ever-increasing knowledge base aimed at providing high quality care at
cost effective means. Finding a suitable medication that would provide
adequate analgesia needing less frequent rebolusing of additional local
anesthetics improves quality of care by decreasing exposure of unnecessary
medications to the parturient and relieving increased workloads on anesthesia
personnel.

Project Objectives
1. To achieve verbal pain scores of the parturients of less than four out of ten
post epidural insertion/initial loading dose within sixty minutes.
2. To achieve a top-off bolus rate of less than ten percent.

Data/Results

Conclusions

- Thirty-two participants were included in the ropivacaine group while
twenty-nine participants were included in the bupivacaine with fentanyl
group for analysis.
- Ages of the participants in the ropivacaine group ranged from 18 to 36
years old with a mean age of 25.3.
- Ages of the participants ranged from 19 to 33 years old with a mean age of
25.
- Pre and post epidural numerical pain scores for the ropivacaine group
indicated mean scores of 9.0 and 1.1, respectively.
- Pre and post epidural numerical pain scores in the bupivacaine with
fentanyl group indicated mean scores of 8.7 and 0.9, respectively.
- In the ropivacaine group, approximately 19 percent of the 32 parturients
did not require top-off boluses. However, 71 percent of the parturients
required at least one top-off bolus to achieve adequate pain control
indicated on a histogram (Figure 1).
- In the bupivacaine with fentanyl group, 90% of the 29 parturients did not
require top-off boluses, while only 10 percent required at least one top-off
bolus to achieve adequate pain control (Figure 2).

The results of the numeric pain score analysis showed that both ropivacaine
and bupivacaine with fentanyl groups were equally effective in the treatment
of labor pain within the first hour after the intervention. However, the
ropivacaine group had higher occurrences of rebolus demands, while the
bupivacaine with fentanyl group had only a minimal amount. Sample sizes of
both groups were very similar and the results of the analysis correlate with
patient and staff verbal feedback regarding medication efficacy. Additionally,
parturients in the bupivacaine with fentanyl group did not experience
cardiotoxic or excessive motor block effects. The results correlate with
Merson’s (2001) study where bupivacaine provides better duration and quality
of labor analgesia relief than ropivacaine.

Design
A prospective, time-series, quantitative design was used to explore the
efficacy of a new service line medication, bupivacaine 0.1 percent with
fentanyl 2mcg/ml, in laboring parturients.
Verbal pain scores that were reported to the anesthesia provider just prior to
the bolus and an hour after epidural administration and initial bolus were
recorded and statistically analyzed through paired samples t tests to determine
clinically significant differences.
Ropivacaine data was based on retrospective chart audits for one month.
Bupivacaine with fentanyl data was based on prospective information
collected by one provider for one month.

Framework
The theoretical framework used for the project was the Johns Hopkins
Nursing evidence-based practice model (JHNEBP). The first component of
the model, practice question, addressed the topics of effective labor analgesia
relief and which medication was considered more effective in providing labor
pain relief, ropivacaine or bupivacaine with fentanyl. The second component,
evidence, incorporated both research and non-research factors, such as
findings from the literature and patient/staff verbal feedback. The third
component, translation, focused on whether bupivacaine with fentanyl was
feasible for implementation. The pharmacy department and anesthesia staff
were interviewed to receive feedback on long-term purchasing and practice
issues.

Figure 1
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Population/Setting
The initiative focused on all parturients in the Morongo basin community
admitted for labor at a fifty-five-bed rural community hospital in Southern
California. The retrospective component of the initiative was based on a onemonth chart audit convenience sampling of parturients who received epidurals
from multiple providers and were placed on ropivacaine solutions. The
prospective component of the initiative based on a one-month convenience
sampling of parturients who labor at SCH, receive epidurals from one
anesthesia provider, and are placed on bupivacaine with fentanyl solutions.

Data Collection

Figure 2

- One anesthesia provider collected the entire data for both retrospective and
prospective components of the initiative.
- The retrospective component involved chart audits in January 2015
accessed through “idoc”.
- The prospective component involved data collection from parturients in
mid December to mid January 2017.
- Verbal pain scores were obtained five minutes prior to epidural insertion
and one-hour post epidural insertion and initial medication bolus. Data on
additional top off boluses of bupivacaine 0.25 percent were obtained until
delivery.
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Figure 3. Bupivacaine with fentanyl quality improvement poster of parturient women in
SCH.
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